Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 6;19(1):299.
doi: 10.1186/s12906-019-2722-2.

Placebo design in WHO-registered trials of Chinese herbal medicine need improvements

Xuan Zhang  1 , Ran Tian  1 , Chen Zhao  1 , Xudong Tang  2 , Aiping Lu  1 , Zhaoxiang Bian  3
Affiliations

Placebo design in WHO-registered trials of Chinese herbal medicine need improvements

Xuan Zhang et al. BMC Complement Altern Med. .

Abstract

Background: Physical identical and pharmacological inert are the basic requirements for placebo design, which are essential in clinical trials to evaluate the efficacy of an intervention. However, it is difficult to makeup a placebo of Chinese herbal medicine (CHM) because of special color, taste and smell, etc. Currently, there is no specific requirements and standards for the creation of a CHM-placebo. The purpose of this study is to review the characteristics of the CHM-placebo design and application in registered clinical trials with CHM interventions and identify the common problems, if any.

Methods: The World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) was systematically searched for CHM interventional trials with placebo-controlled design up to 31 December 2017. Registered information of each included trial was collected from specific registries involved in ICTRP through hyperlinks. Descriptive statistics were used to analyze the characteristics of placebo design in CHM trial registrations.

Results: A total of 889 CHM interventional trials were registered from 1999 to 2017, and 40.8% (363) of them included CHM-placebo control design. The common ways of their design were: placebo as sole control (191, 52.6%); placebo as add-on control with baseline treatment (84, 23.1%); and placebo as double-dummy control (57, 15.7%). Among 363 included trials, 46 (12.7%) reported the compositions of placebos, including CHM ingredients (17 trials), excipients and other agents (29 trials). 2 (0.6%) reported pharmacological inert testing, and 52 (14.3%) descripted their placebos to be physically identical with the CHMs. 14 (3.9%) reported quality control of placebos, and 2 (0.6%) provided blinding assessment of placebos.

Conclusions: The placebos included in most CHM trial registrations is not optimal in terms of placebo design, application, evaluation and reporting. Specific guidelines or standards of CHM-placebo design, including usage requirements, preparation specifications, quality assessments and reporting guidelines should be developed thus to improve their quality.

Keywords: Chinese herbal medicine (CHM); Clinical trial registration; Placebo; Traditional Chinese medicine (TCM); WHO ICTRP.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of data identified, included and excluded
Fig. 2
Fig. 2
Number of registered CHM-placebo controlled clinical trials from 2002 to 2017
Fig. 3
Fig. 3
Distribution of CHM-placebo controlled trials in 7 registries from 2002 to 2017
See this image and copyright information in PMC

References

    1. Bian ZX, Moher D, Dagenais S, Li YP, Liu L, Wu TX, et al. Improving the quality of randomized controlled trials in Chinese herbal medicine, part II: control group design. Zhong Xi Yi Jie He Xue Bao. 2006;4(2):130–136. doi: 10.3736/jcim20060205. - DOI - PubMed
    1. Xie ZJ, Wen CP, Fan YS. Discussion on quality control of randomized, double-blind and placebo controlled clinical trial of Chinese medicine. Chin J Tradit Chin Med Pharm. 2012;27(6):1479–1481.
    1. Dube A, Manthata LN, Syce JA. The design and evaluation of placebo material for crude herbals: Artemisia afra herb as a model. Phytother Res. 2007;21(5):448–451. doi: 10.1002/ptr.2084. - DOI - PubMed
    1. Shapiro AK. A historical and heuristic definition of the placebo. Psychiatry. 1964;27:52–58. doi: 10.1080/00332747.1964.11023375. - DOI - PubMed
    1. Stewart-Williams S, Podd J. The placebo effect: dis-solving the expectancy versus conditioning debate. Psychol Bull. 2004;130(2):324–340. doi: 10.1037/0033-2909.130.2.324. - DOI - PubMed

MeSH terms

Substances